Materials and Methods: Models were used to estimate NAFLD and NASH disease progression,
primarily based on changes in adult prevalence rates of adult obesity and DM. The …

Limited clinical trial data has shown high efficacy of co-formulated ledipasvir/sofosbuvir (LDV/SOF)
in the treatment of hepatitis C virus (HCV) genotype (GT)-4 infected cirrhotic patients. …

Background & Aims Limited data have shown high efficacy of co‐formulated ombitasvir/paritaprevir/ritonavir
( OBV / PTV /r) in the treatment of hepatitis C virus ( HCV ) genotype ( GT )‐4…

Background and Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing in Saudi Arabia (SA), but descriptions of the clinical and metabolic characteristics of …

This is a case report of a 42-year-old female patient with chronic inactive hepatitis B virus (HBV)
infection who presented with relapsing chronic inflammatory demyelinating …

Background: Approximately, 257 million people have CHB globally, with 887,000 deaths from
HBV-related cirrhosis or HCC in 2015. In response, WHO introduced the HBV elimination …

Intraluminal endoscopic surgery is a recent innovation to minimally invasive surgery. This
technique provides access to the peritoneal cavity through a natural orifice. The technique …

Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding
whether to initiate or continue treatment with this medication. While mostly associated with long-…

Background: Hepatitis B virus (HBV) continues to be a significant global health problem
despite vaccination programs and effective antiviral drugs.[The study aim was to assess …

BACKGROUND: Recurrent hepatitis C (HCV) after liver transplantation (LT) is often more
aggressive and treatments tend to be less successful. Pegylated-interferon and ribavirin are …